Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

1.

Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides.

Hammond SM, McClorey G, Nordin JZ, Godfrey C, Stenler S, Lennox KA, Smith CI, Jacobi AM, Varela MA, Lee Y, Behlke MA, Wood MJ, Andaloussi SE.

Mol Ther Nucleic Acids. 2014 Nov 25;3:e212. doi: 10.1038/mtna.2014.63.

PMID:
25423116
2.

Kir3 channel ontogeny - the role of Gβγ subunits in channel assembly and trafficking.

Zylbergold P, Sleno R, Khan SM, Jacobi AM, Belhke MA, Hébert TE.

Front Cell Neurosci. 2014 Apr 14;8:108. doi: 10.3389/fncel.2014.00108. eCollection 2014.

3.

[Rituximab for treatment of Felty’s syndrome].

Becker H, Appel H, Fassbinder T, Heitzmann D, Willeke P, Jacobi AM.

Z Rheumatol. 2014 Jun;73(5):465-6, 468. German.

PMID:
24659095
4.

Imaging of fetal thymus in pregnant women with rheumatic diseases.

Warby AC, Amler S, Jacobi AM, Hammer K, Möllmann U, Falkenberg MK, Möllers M, Kiesel L, Klockenbusch W, Schmitz R.

J Perinat Med. 2014 Sep;42(5):635-9. doi: 10.1515/jpm-2013-0314.

PMID:
24552965
5.

Inosine-mediated modulation of RNA sensing by Toll-like receptor 7 (TLR7) and TLR8.

Sarvestani ST, Tate MD, Moffat JM, Jacobi AM, Behlke MA, Miller AR, Beckham SA, McCoy CE, Chen W, Mintern JD, O'Keeffe M, John M, Williams BR, Gantier MP.

J Virol. 2014 Jan;88(2):799-810. doi: 10.1128/JVI.01571-13. Epub 2013 Nov 13.

6.

Spinal NTS2 receptor activation reverses signs of neuropathic pain.

Tétreault P, Beaudet N, Perron A, Belleville K, René A, Cavelier F, Martinez J, Stroh T, Jacobi AM, Rose SD, Behlke MA, Sarret P.

FASEB J. 2013 Sep;27(9):3741-52. doi: 10.1096/fj.12-225540. Epub 2013 Jun 11.

7.

Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs.

Ramachandran S, Karp PH, Osterhaus SR, Jiang P, Wohlford-Lenane C, Lennox KA, Jacobi AM, Praekh K, Rose SD, Behlke MA, Xing Y, Welsh MJ, McCray PB Jr.

Am J Respir Cell Mol Biol. 2013 Oct;49(4):544-51. doi: 10.1165/rcmb.2012-0430OC.

8.

Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro.

Ramachandran S, Krishnamurthy S, Jacobi AM, Wohlford-Lenane C, Behlke MA, Davidson BL, McCray PB Jr.

Am J Physiol Lung Cell Mol Physiol. 2013 Jul 1;305(1):L23-32. doi: 10.1152/ajplung.00426.2012. Epub 2013 Apr 26.

9.

[Interleukin-1-mediated diseases].

Holzinger D, Becker H, Jacobi AM.

Internist (Berl). 2013 Apr;54(4):408-15. doi: 10.1007/s00108-012-3186-3. German.

PMID:
23460390
10.

Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins.

Fernandez G, Zaikos TD, Khan SZ, Jacobi AM, Behlke MA, Zeichner SL.

J Virol. 2013 Apr;87(7):3966-78. doi: 10.1128/JVI.03251-12. Epub 2013 Jan 30.

11.

Deep Sequencing Analyses of DsiRNAs Reveal the Influence of 3' Terminal Overhangs on Dicing Polarity, Strand Selectivity, and RNA Editing of siRNAs.

Zhou J, Song MS, Jacobi AM, Behlke MA, Wu X, Rossi JJ.

Mol Ther Nucleic Acids. 2012 Apr 3;1:e17. doi: 10.1038/mtna.2012.6.

12.

[B-cell-directed therapy in patients with connective tissue diseases].

Jacobi AM, Dörner T.

Dtsch Med Wochenschr. 2012 Sep;137(36):1755-7. doi: 10.1055/s-0032-1305208. Epub 2012 Aug 29. Review. German.

PMID:
22933200
13.

Wetting behavior and drainage of water droplets on microgrooved brass surfaces.

Rahman MA, Jacobi AM.

Langmuir. 2012 Sep 18;28(37):13441-51. doi: 10.1021/la302669g. Epub 2012 Sep 4.

PMID:
22909187
14.

RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma.

Weinstein S, Emmanuel R, Jacobi AM, Abraham A, Behlke MA, Sprague AG, Novobrantseva TI, Nagler A, Peer D.

PLoS One. 2012;7(8):e43343. doi: 10.1371/journal.pone.0043343. Epub 2012 Aug 14.

15.

A microRNA network regulates expression and biosynthesis of wild-type and DeltaF508 mutant cystic fibrosis transmembrane conductance regulator.

Ramachandran S, Karp PH, Jiang P, Ostedgaard LS, Walz AE, Fisher JT, Keshavjee S, Lennox KA, Jacobi AM, Rose SD, Behlke MA, Welsh MJ, Xing Y, McCray PB Jr.

Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13362-7. doi: 10.1073/pnas.1210906109. Epub 2012 Aug 1.

16.

Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus.

Eickenberg S, Mickholz E, Jung E, Nofer JR, Pavenstadt HJ, Jacobi AM.

Arthritis Res Ther. 2012;14(3):R110.

17.

Ultrasonication effects on thermal and rheological properties of carbon nanotube suspensions.

Ruan B, Jacobi AM.

Nanoscale Res Lett. 2012 Feb 14;7:127. doi: 10.1186/1556-276X-7-127.

18.

Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.

Aringer M, Burkhardt H, Burmester GR, Fischer-Betz R, Fleck M, Graninger W, Hiepe F, Jacobi AM, Kötter I, Lakomek HJ, Lorenz HM, Manger B, Schett G, Schmidt RE, Schneider M, Schulze-Koops H, Smolen JS, Specker C, Stoll T, Strangfeld A, Tony HP, Villiger PM, Voll R, Witte T, Dörner T.

Lupus. 2012 Apr;21(4):386-401. doi: 10.1177/0961203311426569. Epub 2011 Nov 9. Review.

PMID:
22072024
19.

Equilibrium contact angles of liquid droplets on ideal rough solids.

Kang HC, Jacobi AM.

Langmuir. 2011 Dec 20;27(24):14910-8. doi: 10.1021/la2031413. Epub 2011 Nov 23.

PMID:
22053925
20.

Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade.

Mohr M, Jacobi AM.

Scand J Rheumatol. 2011;40(5):400-1. doi: 10.3109/03009742.2011.599072. No abstract available.

PMID:
21961704
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk